Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.4 EUR | -0.61% | -4.09% | -43.84% |
Apr. 16 | Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024 | |
Apr. 16 | Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 18.19M 19.74M | Sales 2025 * | 23.47M 25.46M | Capitalization | 25.42M 27.58M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | 1M 1.08M | EV / Sales 2024 * | 1.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.08 x |
P/E ratio 2024 * |
53.2
x | P/E ratio 2025 * |
12.6
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.1% |
Latest transcript on Marinomed Biotech AG
1 day | -0.61% | ||
1 week | -4.09% | ||
Current month | -3.53% | ||
1 month | -18.00% | ||
3 months | -33.33% | ||
6 months | -57.95% | ||
Current year | -43.84% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 05-12-31 | |
Founder | 56 | 05-12-31 | |
Pascal Schmidt
DFI | Director of Finance/CFO | 52 | 18-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 07-12-31 | |
Brigitte Ederer
BRD | Director/Board Member | 68 | 18-11-20 |
Director/Board Member | - | 22-06-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 16.4 | -0.61% | 400 |
24-05-16 | 16.5 | -1.20% | 649 |
24-05-15 | 16.7 | -1.47% | 1,961 |
24-05-14 | 16.95 | -0.29% | 347 |
24-05-13 | 17 | -0.58% | 359 |
Delayed Quote Wiener Boerse, May 17, 2024 at 03:49 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.84% | 27.63M | |
-2.32% | 92.59B | |
+3.16% | 41.43B | |
-11.10% | 33.49B | |
+53.80% | 25.06B | |
-9.41% | 12.77B | |
-12.25% | 11.58B | |
-44.00% | 11.35B | |
+5.69% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- MARI Stock